Lutronic Vision’s R:GEN® is the world’s first laser for Selective Retina Therapy.  Our patented R:GEN® system is a fully integrated laser platform that safely and precisely targets the problematic Retina Pigmented Epithelium (RPE) cells without damaging neighboring photoreceptors, inducing cell regeneration and functional restoration. The Selective Retina Therapy enabled by R:GEN® is bringing better vision and improved quality of life for patients with Age-related Macular Degeneration, Central Serous Chorioretinopathy, and other RPE-related conditions.